Turning the Tide on Resistance: Emerging Therapies for Multidrug-Resistant Gram-Negative Pathogens
Panelists discuss the evolving management of multidrug-resistant Gram-negative pathogens, highlighting current challenges, emerging therapies, clinical trial data, regulatory considerations, and strategies for integrating new treatments into clinical practice.
EP. 1: Pathogen prevalence, emerging threats, and regional resistance patterns
Panelists discuss emerging therapies for multidrug-resistant Gram-negative pathogens, focusing on the rising threat of antimicrobial resistance, evolving resistance mechanisms like extended-spectrum β-lactamases (ESBLs) and New Delhi metallo-β-lactamases (NDMs), regional variability in pathogen prevalence, and the clinical implications for treatment in inpatient and outpatient settings.
Watch
EP. 2: The role of rapid diagnostics and collaboration in antibiotic stewardship
Panelists discuss the pivotal role of microbiology laboratories and rapid diagnostic technologies in managing multidrug-resistant infections, highlighting their impact on timely treatment, antibiotic stewardship, and the need for interdisciplinary collaboration to effectively interpret and act on resistance data.
Watch
